Nasdaq · CIK 0000706698
UTMD UTAH MEDICAL PRODUCTS INC
Insider trading from SEC Form 4. Last filing Nov 25, 2025.
UTAH MEDICAL PRODUCTS INC (UTMD) has 4 SEC Form 4 filings on file from 2 insiders, the latest filed on Nov 25, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at UTAH MEDICAL PRODUCTS INC, scored.
Transactions
Every row filed, 4 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 31, 2025 | Brian Koopman Principal Financial Officer | AGrant or award Employee Stock Option - Right to Buyderivative | +500 | $0.00 | $0 | 5,600 | Nov 25, 2025 |
| Sep 4, 2025 | Brian Koopman Principal Financial Officer | GGift Common Stock | -50 | $62.75 | $3,138 | 832 | Sep 5, 2025 |
| Aug 25, 2025 | Paul O Richins director | GGift Common Stockindirect: See note | -100 | $60.34 | $6,034 | 21,136 | Aug 26, 2025 |
| Nov 1, 2024 | Brian Koopman Principal Financial Officer | AGrant or award Employee Stock Option - Right to Buyderivative | +500 | $0.00 | $0 | 5,100 | Nov 8, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Brian KoopmanPrincipal Financial Officer
- Paul O Richinsdirector
Questions about UTMD
Answered from the filings on this page, as of the latest one.
Are insiders buying UTMD?
No. In the last 90 days no insider at UTAH MEDICAL PRODUCTS INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade UTMD on the open market?
No open-market trade has been scored at UTAH MEDICAL PRODUCTS INC. The latest Form 4 on file was filed on Nov 25, 2025 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at UTAH MEDICAL PRODUCTS INC?
2 people have filed a Form 4 at UTAH MEDICAL PRODUCTS INC, among them Brian Koopman (Principal Financial Officer), Paul O Richins (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.